Canadian Academy of Health Sciences (CAHS), Report: Assessment on Antimicrobial Resistance and Antimicrobial Use in Food Producing Animals | March 2025

This document presents a new WHO initiative to strengthen diagnostic capacity to improve the diagnosis and management of bacterial and fungal infections and associated AMR.

WHO 2023 Antibacterial agents in clinical and preclinical development: an overview and analysis | Technical document | June 14, 2024

This bootcamp video series will help participants make the transition from academic and grant-based research to quality compliant product development, and learn the fundamentals for moving an IVD product from concept through development.
 

WHO bacterial priority pathogens list, 2024 | Report May 17, 2024

Towards specific commitments and action in the response to antimicrobial resistance
GLG (Global Leaders Group on AMR) report | released April 4, 2024

The WHO AWaRe (Access, Watch, Reserve) antibiotic book - Infographics 

Public Health Agency of Canada's five-year (2023 to 2027) blueprint plan

The global research agenda for antimicrobial resistance in human health prioritizes 40 research topics for evidence generation to inform policy by 2030.

Council of Canadian Academies' expert panel describes path to bring critical antibiotics to Canadian market.